HNF1B
protein-codingHNF1 homeobox B, the group of HNF class homeoboxes
Gene summary
This gene encodes a member of the homeodomain-containing superfamily of transcription factors. The protein binds to DNA as either a homodimer, or a heterodimer with the related protein hepatocyte nuclear factor 1-alpha. The gene has been shown to function in nephron development, and regulates development of the embryonic pancreas. Mutations in this gene result in renal cysts and diabetes syndrome and noninsulin-dependent diabetes mellitus, and expression of this gene is altered in some types of cancer. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
- TCF2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~58.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007669
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007669
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019644
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100164
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0020525
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007669
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007455
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007669
Submitter: ClinGen
HNF1B was first reported in relation to autosomal dominant Renal Cysts and Diabetes Syndrome in 1997 (Horikawa et al., PMID: 9398836). An alternative description is Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) – HNF1B. This disease entity consistently includes a primary renal phenotype in which a wide variety of genitourinary developmental malformations may be present, such as renal cysts, interstitial fibrosis, absent or underdeveloped kidney, abnormal nephron development, hypoplastic glomeruli, enlarged renal pelvises, bicornuate uterus, atresia of the vas deferens, rudimentary uterus, vaginal aplasia. Diabetes is typically diagnosed in adolescence or young adulthood, but some families will have carriers who may not have been diagnosed with diabetes but will usually have some evidence of renal pathology that is either congenital or progressive. The disorder has also been referred to as maturity onset diabetes of the young 5 (MODY5) or HNF1B-MODY, as well as Renal Cysts and Diabetes (RCAD; MIM:137920). Treatment for diabetes often includes insulin but optimal management has not been established. Other variable features of the syndrome may include hypomagnesemia, hyperuricemia, pancreatic exocrine insufficiency, hepatic dysfunction such as cholestasis, and intellectual disability (possibly more often when caused by large deletion of 17q12). Numerous variants have been reported in humans per ClinVar, especially whole gene deletions. Evidence supporting this gene-disease relationship includes case-level and experimental data. Summary of case-level and experimental data: 18 points. Variants in this gene have been reported in at least 13 probands in 7 publications (PMIDS: 9398836, 12161522, 25705165, 25754277, 25441779, 15068978, 20378641). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism for disease is heterozygous loss of function. This gene-disease association is supported by expression studies, animal models, and in vitro functional assays. In summary, HNF1B is definitively associated with autosomal dominant Renal Cysts and Diabetes Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Monogenic Diabetes Gene Curation Expert Panel (12/10/2019) in collaboration with the ClinGen Kidney Cystic and Ciliopathy Disorders Gene Curation Expert Panel (1/19/2021) according to SOP Version 8.
Inheritance Pattern: AD
Disease ID:MONDO:0007669
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0019981
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019645
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007669
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0015268
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Genitourinary; Oncologic; Renal
Intervention: Oncologic
Rationale: Surveillance and early detection of and treatment for malignancy may decrease morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HNF1B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000458.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 146 | 148 | |||
| missense | 17 | 82 | 305 | 21 | 3 | 428 |
| nonsense | 36 | 19 | 55 | |||
| start loss | 2 | 2 | ||||
| frameshift | 74 | 49 | 2 | 125 | ||
| splice donor/acceptor (+/-2bp) | 23 | 10 | 4 | 37 | ||
| Total | 152 | 160 | 313 | 167 | 3 | 795 |
Highest pathogenic variant AF is 0.000033231376
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000449.1 | 9 | MANE Select | |
| Ensembl | ENSP00000480291.1 | 9 | MANE Select | |
| RefSeq | NP_001159395.1 | 9 | Standard | |
| RefSeq | NP_001291215.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| hnf1ba | Danio rerio | Structure: hair cell Quality: mislocalised abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Maturity onset diabetes of the young - Homo sapiens (human)
- Anti-diabetic Drug Potassium Channel Inhibitors Pathway, Pharmacodynamics
- Endoderm Differentiation
Biological Process
- negative regulation of transcription by RNA polymerase II
- endodermal cell fate specification
- kidney development
- inner cell mass cell differentiation
- regulation of transcription by RNA polymerase II
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity
- protein binding
- protein homodimerization activity
Cellular Component
- nucleus
- nucleoplasm
- transcription factor complex
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor, probably binds to the inverted palindrome 5'-GTTAATNATTAAC-3'.;
- Disease
- DISEASE: Renal cysts and diabetes syndrome (RCAD) [MIM:137920]: An autosomal dominant disorder comprising non-diabetic renal disease resulting from abnormal renal development, and diabetes, which in some cases occurs earlier than age 25 years and is thus consistent with a diagnosis of maturity-onset diabetes of the young (MODY5). The renal disease is highly variable and includes renal cysts, glomerular tufts, aberrant nephrogenesis, primitive tubules, irregular collecting systems, oligomeganephronia, enlarged renal pelves, abnormal calyces, small kidney, single kidney, horseshoe kidney, and hyperuricemic nephropathy. Affected individuals may also have abnormalities of the genital tract. {ECO:0000269|PubMed:10484768, ECO:0000269|PubMed:10672455, ECO:0000269|PubMed:11845238, ECO:0000269|PubMed:11918730, ECO:0000269|PubMed:14583183, ECO:0000269|PubMed:15001636, ECO:0000269|PubMed:15068978, ECO:0000269|PubMed:15181075, ECO:0000269|PubMed:15930087, ECO:0000269|PubMed:16249435}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:12161522}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; DISEASE: Prostate cancer, hereditary, 11 (HPC11) [MIM:611955]: A condition associated with familial predisposition to cancer of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:18264097}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.708
Intolerance Scores
- LoFtool
- 0.0380
- RVIS EVS
- -0.54
- RVIS percentile EVS
- 20.26
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.914
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |